We are proud to announce a joint doctoral programme funded within Horizon Europe Marie Skłodowska-Curie Doctoral Networks that will exploit unique expertise and advanced technologies at 12 leading universities, 3 research centers, a hospital, 12 non-academic institutions including SMEs, a large pharma company, a Health industry association, and a patient organization across EU, UK, Israel, USA and China.
With the aim of training doctoral candidates from different countries across Europe and beyond, this project focuses on covering 5 themes:
We are proud to announce our group won the prestigious call FISR - 2019 among more than hundreds of proposals. The investment is intended to finance specific interventions of particular strategic importance.
The financed two-year project (2021-23), named PROLEISH, will be developed counting on 3 strategic partners:
We are involved in the MuTaLig COST Action project. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks.These networks offer an open space for collaboration among scientists across Europe (and beyond) and thereby give impetus to research advancements and innovation.
B2AlzD2 is a "laboratory without walls" aimed to strengthen cooperation between teams within FaBiT Department in Bologna and Brazilian Partners. The main objective of B2AlzD2 is to strengthen the network involving scientists from the FaBit Department and four Brazilian universities (UNB, UFRJ, UFMG and RibeiraoPreto-USP) who share a common interest in research and teaching in the field of new drug discovery for Alzheimer's disease. To achieve this goal we created a Joint Lab to promote PhD student exchanges between the patner universities.
twitter profile: https://twitter.com/b2alzd2